Science ❯ Biology ❯ Immunology

Autoimmune Diseases

Cytokines Peripheral Immune Tolerance T Cells Clinical Trials Foxp3 Gene Regulatory T Cells T Cell Function Rheumatoid Arthritis T Lymphocytes Type 1 Diabetes Pathogenesis IPEX Syndrome

Low-Dose Transplant Drug Preserves Beta Cells in Young People With Type 1 Diabetes, Phase 2 Trial Finds

An adaptive trial in newly diagnosed patients identified 0.5 mg/kg as the minimum effective dose with fewer adverse events than a higher dose.